未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Sacubitril/Valsartan Attenuates Inflammation and Fibrosis Associated With Decreased Integrin α8 and Inhibits Hepatocarcinogenesis in a Rat Model of Metabolic Dysfunction-Associated Steatohepatitis沙库比曲/缬沙坦减轻与整合素α8降低相关的炎症和纤维化，并在代谢功能障碍相关脂肪性肝炎大鼠模型中抑制肝细胞癌发生。
Kawamura, Hayato; Naiki-ito, Aya; Kuang, Xiaochen; Murakami, Akihiro; Komura, Masayuki; Suzuki, Takanori; Kato, Hiroyuki; Nagayasu, Yuko; Matsuura, Kentaro; Fujiwara, Kei; Kataoka, Hiromi; Takahashi, Satoru 分享 收藏 The Low Platelet Count at the Start of Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Deteriorated Liver Function at the Time of Disease Progression Thereafter: A Multicenter AnalysisSato, Ryo; Suzuki, Takanori; Matsuura, Kentaro; Kato, Daisuke; Hayashi, Katsumi; Okayama, Kohei; Okumura, Fumihiro; Sobue, Satoshi; Kusakabe, Atsunori; Hasegawa, Izumi; Narita, Kiyoto; Mizoshita, Tsutomu; Kimura, Yoshihide; Kondo, Hiromu; Kojima, Hisayo; Hayashi, Kazuki; Ozasa, Atsushi; Kawamura, Hayato; Fujiwara, Kei; Nojiri, Shunsuke; Kataoka, Hiromi 分享 收藏 分享 收藏 分享 收藏 Neutrophil-to-lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysisdurvalumab联合tremelimumab治疗第二疗程开始时的中性粒细胞与淋巴细胞比率预测晚期肝细胞癌患者的治疗效果: 一项多中心分析Suzuki, Takanori; Matsuura, Kentaro; Sobue, Satoshi; Kato, Daisuke; Hayashi, Katsumi; Kondo, Hiromu; Anbe, Kaiki; Mizoshita, Tsutomu; Okayama, Kohei; Okumura, Fumihiro; Kimura, Yoshihide; Ozasa, Atsushi; Inada, Hiroki; Tokunaga, Takayuki; Narahara, Satoshi; Kawamura, Hayato; Fujiwara, Kei; Nojiri, Shunsuke; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivationSuzuki, Takanori; Tamori, Akihiro; Matsuura, Kentaro; Inoue, Takako; Kusumoto, Shigeru; Hagiwara, Shinya; Sagi, Haruka; Kaneko, Atsushi; Murakami, Shuko; Kawamra, Hayato; Fujiwara, Kei; Aoyagi, Katsumi; Enomoto, Masaru; Kozuka, Ritsuzo; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 分享 收藏 Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B PatientsSuzuki, Takanori; Matsuura, Kentaro; Inoue, Takako; Sasada, Keiko; Ogawa, Shintaro; Watanabe, Takehisa; Kawamura, Hayato; Fujiwara, Kei; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 Serum interleukin-6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysisSuzuki, Takanori; Matsuura, Kentaro; Suzuki, Yuta; Okumura, Fumihiro; Nagura, Yoshihito; Sobue, Satoshi; Matoya, Sho; Miyaki, Tomokatsu; Kimura, Yoshihide; Kusakabe, Atsunori; Narahara, Satoshi; Tokunaga, Takayuki; Nagaoka, Katsuya; Murakami, Shuko; Inoue, Takako; Kuroyanagi, Keita; Kawamura, Hayato; Fujiwara, Kei; Nojiri, Shunsuke; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agentsSuzuki, Takanori; Matsuura, Kentaro; Nagura, Yoshihito; Ito, Kyoko; Ogawa, Shintaro; Kawamura, Hayato; Fujiwara, Kei; Nagaoka, Katsuya; Iio, Etsuko; Watanabe, Takehisa; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 分享 收藏 Quantitative measurements of M2BPGi depend on liver fibrosis and inflammationUojima, Haruki; Yamasaki, Kazumi; Sugiyama, Masaya; Kage, Masayoshi; Ishii, Norihiro; Shirabe, Ken; Hidaka, Hisashi; Kusano, Chika; Murakawa, Miyako; Asahina, Yasuhiro; Nishimura, Takashi; Iijima, Hiroko; Sakamoto, Kazumasa; Ito, Kiyoaki; Amano, Keisuke; Kawaguchi, Takumi; Tamaki, Nobuharu; Kurosaki, Masayuki; Suzuki, Takanori; Matsuura, Kentaro; Taketomi, Akinobu; Joshita, Satoru; Umemura, Takeji; Nishina, Sohji; Hino, Keisuke; Toyoda, Hidenori; Yatsuhashi, Hiroshi; Mizokami, Masashi 分享 收藏 分享 收藏 New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease慢性肝病Mac-2结合蛋白糖基化异构体定量测定的新化学发光酶免疫分析Uojima, Haruki; Nakabayashi, Kadzuki; Yamasaki, Kazumi; Sugiyama, Masaya; Ishii, Norihiro; Shirabe, Ken; Kyoutou, Takuya; Ueda, Koji; Takahama, Yoichi; Tamaki, Nobuharu; Kurosaki, Masayuki; Hidaka, Hisashi; Kusano, Chika; Amano, Keisuke; Kawaguchi, Takumi; Taketomi, Akinobu; Joshita, Satoru; Umemura, Takeji; Murakawa, Miyako; Asahina, Yasuhiro; Suzuki, Takanori; Matsuura, Kentaro; Nishimura, Takashi; Iijima, Hiroko; Sakamoto, Kazumasa; Ito, Kiyoaki; Nishina, Sohji; Hino, Keisuke; Toyoda, Hidenori; Yatsuhashi, Hiroshi; Kage, Masayoshi; Mizokami, Masashi 分享 收藏 Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearanceSuzuki, Takanori; Matsuura, Kentaro; Watanabe, Takehisa; Matsui, Takeshi; Ogawa, Shintaro; Kawamura, Hayato; Kuno, Kayoko; Fujiwara, Kei; Nojiri, Shunsuke; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 Serum inducible protein 10 kDa/C-X-C motif chemokine 10 levels predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agentssNagura, Yoshihito; Suzuki, Takanori; Matsuura, Kentaro; Ogawa, Shintaro; Kawamura, Hayato; Kuno, Kayoko; Fujiwara, Kei; Nojiri, Shunsuke; Nagaoka, Katsuya; Iio, Etsuko; Watanabe, Takehisa; Kataoka, Hiromi; Tanaka, Yasuhito 分享 收藏 The neutrophil-to-lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysisMatoya, Sho; Suzuki, Takanori; Matsuura, Kentaro; Suzuki, Yuta; Okumura, Fumihiro; Nagura, Yoshihito; Sobue, Satoshi; Kuroyanagi, Keita; Kusakabe, Atsunori; Koguchi, Hiroki; Hasegawa, Izumi; Miyaki, Tomokatsu; Tanaka, Yoshito; Kondo, Hiromu; Kimura, Yoshihide; Ozasa, Atsushi; Kawamura, Hayato; Kuno, Kayoko; Fujiwara, Kei; Nojiri, Shunsuke; Kataoka, Hiromi 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
.png)
HEPATOLOGY RESEARCH